Sleep Disorders Trial, Recruiting NCT06250725 Sponsor: Emory University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06250725
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people living with cognitive impairment:

  • People who have been diagnosed with Alzheimer's Disease or a related form of dementia, or whose caregiver has reported that they likely have some level of memory or thinking problems
  • People who score between 12 and 24 on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA)
  • People who have had one or more sleep problems (such as trouble sleeping) at least three nights per week, as measured by a standard behaviour assessment tool
  • People who have an eligible caregiver participating alongside them in the trial
  • People who are able to take part in the trial's sessions

For caregivers:

  • Adults aged 18 or older who live in the same home as the person with cognitive impairment
  • People who regularly help the person they care for with at least one basic daily task (such as bathing or eating) or at least one broader everyday task (such as managing medications or finances), for the past six months
  • People who have had trouble falling asleep or staying asleep for the past three months, or who score 5 or higher on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index (PSQI)

Who may not be able to join:

  • People living with cognitive impairment whose condition is assessed as moderate to severe
  • Anyone under 18 years of age
  • Women who are pregnant
  • People who are currently in prison
  • People who are not able to clearly understand English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Glenna Brewster, PhD, RN, FNP, Emory University

Phone: (404) 712-9164

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in insomnia; Change in Sleep Efficiency; Change in in Sleep Onset Latency; Change in Wake After Sleep Onset; Adherence with Study Interventions (feasibility); Satisfaction with intervention components

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov